A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
TOTW 3 Predictions FC 24: Odegaard, Watkins, Correa, Martinez
Who is Grizzy? Local activist claims Rudy Farias' mom Janie Santana is a 'catfish' on Internet
Fans of the 'King of YouTube' MrBeast want him to dethrone Khaby Lame as most-followed creator on TikTok
Revamp your PC with Windows 11 Pro for under $30
Adin Ross: Here's what we know about Kick star's diamond jewelry worth $5.2M
Bluesky is facing community backlash after letting users register accounts with racial slurs
iPhone Maker Foxconn Beats Expectations. Apple Stock Edges Higher.
Alibaba, NIO, XPeng Stocks Climb. Chinese Businesses Get a Regulatory Boost.